| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Reduced lopinavir exposure during pregnancy.
|
AIDS
|
2006
|
3.98
|
|
2
|
Adherence to antiretrovirals among US women during and after pregnancy.
|
J Acquir Immune Defic Syndr
|
2008
|
2.38
|
|
3
|
Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results.
|
AIDS
|
2008
|
2.35
|
|
4
|
Cigarettes butts and the case for an environmental policy on hazardous cigarette waste.
|
Int J Environ Res Public Health
|
2009
|
2.05
|
|
5
|
Long-term observation of adolescents initiating HAART therapy: three-year follow-up.
|
AIDS Res Hum Retroviruses
|
2007
|
1.84
|
|
6
|
Lopinavir exposure with an increased dose during pregnancy.
|
J Acquir Immune Defic Syndr
|
2008
|
1.65
|
|
7
|
Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol.
|
Arch Pediatr Adolesc Med
|
2004
|
1.44
|
|
8
|
It is time to plan the tobacco endgame.
|
BMJ
|
2014
|
1.43
|
|
9
|
End-of-life care conversations with heart failure patients: a systematic literature review and narrative synthesis.
|
Br J Gen Pract
|
2011
|
1.42
|
|
10
|
Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women.
|
Antimicrob Agents Chemother
|
2004
|
1.35
|
|
11
|
Lopinavir tablet pharmacokinetics with an increased dose during pregnancy.
|
J Acquir Immune Defic Syndr
|
2010
|
1.33
|
|
12
|
Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women.
|
Antimicrob Agents Chemother
|
2006
|
1.32
|
|
13
|
Atazanavir pharmacokinetics with and without tenofovir during pregnancy.
|
J Acquir Immune Defic Syndr
|
2011
|
1.24
|
|
14
|
Complex role of the IL-4 receptor alpha in a murine model of airway inflammation: expression of the IL-4 receptor alpha on nonlymphoid cells of bone marrow origin contributes to severity of inflammation.
|
J Immunol
|
2004
|
1.13
|
|
15
|
A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.09
|
|
16
|
Discussing an uncertain future: end-of-life care conversations in chronic obstructive pulmonary disease. A systematic literature review and narrative synthesis.
|
Thorax
|
2012
|
1.04
|
|
17
|
Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response.
|
J Infect Dis
|
2005
|
1.02
|
|
18
|
Downregulation of missing in metastasis gene (MIM) is associated with the progression of bladder transitional carcinomas.
|
Cancer Invest
|
2007
|
1.01
|
|
19
|
Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection.
|
Pediatrics
|
2003
|
1.00
|
|
20
|
Early detection and intervention for attention-deficit/hyperactivity disorder.
|
Expert Rev Neurother
|
2011
|
0.97
|
|
21
|
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum.
|
J Acquir Immune Defic Syndr
|
2012
|
0.95
|
|
22
|
Impact of pregnancy on abacavir pharmacokinetics.
|
AIDS
|
2006
|
0.95
|
|
23
|
Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents.
|
AIDS
|
2011
|
0.94
|
|
24
|
Untangling the psychiatric comorbidity of posttraumatic stress disorder in a sample of flood survivors.
|
Compr Psychiatry
|
2002
|
0.93
|
|
25
|
Raltegravir pharmacokinetics during pregnancy.
|
J Acquir Immune Defic Syndr
|
2014
|
0.92
|
|
26
|
Identifying research priorities in nursing and midwifery service delivery and organisation: a scoping study.
|
Int J Nurs Stud
|
2004
|
0.92
|
|
27
|
Midwest U.S. landscape change to 2020 driven by biofuel mandates.
|
Ecol Appl
|
2012
|
0.92
|
|
28
|
Cortactin is implicated in murine zygotic development.
|
Exp Cell Res
|
2009
|
0.91
|
|
29
|
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.
|
Adv Anat Pathol
|
2013
|
0.90
|
|
30
|
Rapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa.
|
Int J Gynaecol Obstet
|
2011
|
0.90
|
|
31
|
The incidence and characteristics of neonatal irreversible lung dysplasia.
|
J Pediatr
|
2002
|
0.89
|
|
32
|
Macrophage LRP1 suppresses neo-intima formation during vascular remodeling by modulating the TGF-β signaling pathway.
|
PLoS One
|
2011
|
0.89
|
|
33
|
Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020A.
|
Pediatr Infect Dis J
|
2015
|
0.86
|
|
34
|
Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT signaling from a cell-based pathway screen.
|
J Med Chem
|
2015
|
0.85
|
|
35
|
Calcium regulation of ciliary motility analysis of axonemal calcium-binding proteins.
|
Methods Cell Biol
|
2009
|
0.84
|
|
36
|
Brightness analysis.
|
Methods Enzymol
|
2013
|
0.84
|
|
37
|
Reduced indinavir exposure during pregnancy.
|
Br J Clin Pharmacol
|
2013
|
0.83
|
|
38
|
SCH 2047069, a novel oral kinesin spindle protein inhibitor, shows single-agent antitumor activity and enhances the efficacy of chemotherapeutics.
|
Mol Cancer Ther
|
2010
|
0.82
|
|
39
|
LRAD3, a novel low-density lipoprotein receptor family member that modulates amyloid precursor protein trafficking.
|
J Neurosci
|
2011
|
0.82
|
|
40
|
Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy.
|
J Acquir Immune Defic Syndr
|
2013
|
0.82
|
|
41
|
Long term tolerability and safety of enfuvirtide for human immunodeficiency virus 1-infected children.
|
Pediatr Infect Dis J
|
2004
|
0.82
|
|
42
|
Multiple genes contribute to the virulent phenotype observed in ferrets of an H5N1 influenza virus isolated from Thailand in 2004.
|
Virology
|
2011
|
0.81
|
|
43
|
Survey for potentially necrotizing spider venoms, with special emphasis on Cheiracanthium mildei.
|
Comp Biochem Physiol C Toxicol Pharmacol
|
2005
|
0.80
|
|
44
|
Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in human immunodeficiency virus 1-infected children.
|
Pediatr Infect Dis J
|
2002
|
0.79
|
|
45
|
Consensus statement of the Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition: indicators recommended for the identification and documentation of pediatric malnutrition (undernutrition).
|
J Acad Nutr Diet
|
2014
|
0.79
|
|
46
|
Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women.
|
Antimicrob Agents Chemother
|
2009
|
0.79
|
|
47
|
GB virus C infection in children with perinatal human immunodeficiency virus infection.
|
Pediatr Infect Dis J
|
2005
|
0.79
|
|
48
|
Improving emergency department door-to-electrocardiogram time in ST segment elevation myocardial infarction.
|
Crit Pathw Cardiol
|
2009
|
0.79
|
|
49
|
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women.
|
J Acquir Immune Defic Syndr
|
2015
|
0.78
|
|
50
|
Single-dose pharmacokinetics of enteric-coated didanosine in HIV-infected children.
|
Antivir Ther
|
2002
|
0.77
|
|
51
|
Water content and other aspects of brittle versus normal fingernails.
|
J Am Acad Dermatol
|
2007
|
0.76
|
|
52
|
Offen et al. respond.
|
Am J Public Health
|
2013
|
0.75
|
|
53
|
Is the current practice providing an integrated approach to the management of LUTS and ED in primary care? An audit and literature review.
|
J Sex Med
|
2007
|
0.75
|
|
54
|
Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women.
|
J Acquir Immune Defic Syndr
|
2016
|
0.75
|
|
55
|
Predictors of outcome for children requiring respiratory extra-corporeal life support: implications for inclusion and exclusion criteria.
|
Intensive Care Med
|
2008
|
0.75
|
|
56
|
Improving Nutrition Students' Knowledge and Perceived Competence to Provide Nutrition Education to Adults with Disabilities via Experiential Learning.
|
J Acad Nutr Diet
|
2017
|
0.75
|
|
57
|
The size, extent and nature of the learning disability nursing research base: a systematic scoping review.
|
Int J Nurs Stud
|
2008
|
0.75
|
|
58
|
Scientific meeting of the American Institute for Psychoanalysis. Disclosure, HIV, and the dialectic of sameness and difference.
|
Am J Psychoanal
|
2004
|
0.75
|
|
59
|
ProCure21: friend or foe to Trust and patient?
|
Health Estate
|
2009
|
0.75
|
|
60
|
1071: CLASSIFICATION OF SEP-1 FAILURE TYPE AND PATIENT OUTCOME.
|
Crit Care Med
|
2016
|
0.75
|
|
61
|
Immunization initiatives. Polio...the finish line is in sight!
|
Can J Public Health
|
2003
|
0.75
|
|
62
|
Hepatitis B testing and diagnosis experiences of patients and primary care professionals in Australia.
|
Aust Fam Physician
|
2017
|
0.75
|
|
63
|
Evaluating habitat vulnerability to hazardous air pollutants in the southeastern United States.
|
Integr Environ Assess Manag
|
2009
|
0.75
|
|
64
|
Energy boost: The effects of consuming caffeine & energy drinks on a long shift.
|
JEMS
|
2014
|
0.75
|
|
65
|
Workforce wellness. Small steps to making healthy lifestyle choices in the workplace.
|
JEMS
|
2013
|
0.75
|